
Opinion|Videos|December 31, 2024
Patient Education and Key Considerations for Initiating Topical JAK Inhibitors
Author(s)Douglas DiRuggiero, DMSc, MHS, PA-C
Key Takeaways
A panelist discusses how initiating topical JAK inhibitors requires thorough patient education about proper application techniques, safety monitoring, and setting realistic expectations for treatment response timelines.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Study Suggests Non-Ablative Fractional Laser Reverses Epigenetic Signatures of Skin Aging
2
Bempikibart Shows Positive Phase 2a Results in Alopecia Areata
3
The Gut-Skin Axis: New Evidence Links Microbiota to Skin Disease via Inflammatory Cytokines
4
Roundtable Discussion Weighs Access and Adherence Challenges in Vitiligo Care
5

















